A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received RevlimidÂ® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment